Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat

Keyphrases

• Active Metabolite 16%
• Aminotransferase Levels 16%
• Ammonia Level 16%
• Aspartate Aminotransferase 16%
• Biochemical Tests 16%
• Cyclooxygenase Inhibitors 100%
• Cyclooxygenase-1 (COX-1) 83%
• Cyclooxygenase-1/2 16%
• Cyclooxygenase-2 66%
• Cyclooxygenase-2 Inhibitors 16%
• Distilled Water 16%
• Factor Level 16%
• Fulminant Hepatic Failure 100%
• Hepatic Encephalopathy 100%
• Histopathological Changes 16%
• Inducible Nitric Oxide Synthase 33%
• Keto 16%
• Liver 16%
• Liver Biochemistry 50%
• Liver Histopathology 16%
• Mortality Rate 33%
• Motor Activity 33%
• MRNA Expression 33%
• No Significant Difference 16%
• NS-398 50%
• Plasma Parameters 16%
• Prostacyclin 16%
• Prostaglandins 33%
• Therapeutic Effect 16%
• Thioacetamide 16%
• Tumor Necrosis Factor-α 33%
• Water Control 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Active Metabolite 16%
• Aspartate Aminotransferase 16%
• COX-2 Inhibitor 16%
• Cyclooxygenase 1 66%
• Cyclooxygenase 1 Inhibitor 16%
• Cyclooxygenase 2 66%
• Distilled Water 16%
• Fulminant Hepatic Failure 100%
• Hepatic Encephalopathy 100%
• Messenger RNA 50%
• Mortality Rate 33%
• Nitric Oxide Synthase 33%
• NS-398 50%
• Prostacyclin 16%
• Prostaglandin 33%
• Prostaglandin Synthase 100%
• Prostaglandin Synthase Inhibitor 16%
• Therapeutic Effect 16%
• Thioacetamide 16%
• Tumor Necrosis Factor 33%

Biochemistry, Genetics and Molecular Biology

• Ammonia Blood Level 7%
• Aspartate Aminotransferase Level 7%
• Blood Level 7%
• COX-2 Inhibitor 7%
• Cyclooxygenase 100%
• Liver Biochemistry 23%
• Messenger RNA 23%
• Metabolite 7%
• Mortality Rate 15%
• Motor Activity 15%
• Nitric Oxide Synthase 15%
• NS-398 23%
• Prostacyclin 7%
• Prostaglandin 15%
• Thioacetamide 7%
• Tumor Necrosis Factor 15%